An increased expression of CXCR4 is associated with the recurrence of glioblastoma after radiochemotherapy and could indicate an activation of the CXCL12-CXCR4 pathway representing an alteration in the angiogenic pattern within the tumor47. Here, CXCR4 is linked to glioblastoma.